1. Home
  2. CLBT vs RCUS Comparison

CLBT vs RCUS Comparison

Compare CLBT & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

SELL

Current Price

$11.84

Market Cap

2.9B

Sector

Technology

ML Signal

SELL

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

SELL

Current Price

$17.34

Market Cap

3.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CLBT
RCUS
Founded
1999
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CLBT
RCUS
Price
$11.84
$17.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$15.21
★ $41.00
AVG Volume (30 Days)
1.8M
★ 2.4M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $247,000,000.00
Revenue This Year
$16.85
N/A
Revenue Next Year
$13.25
N/A
P/E Ratio
$45.29
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.58
$17.43
52 Week High
$19.39
$31.74

Technical Indicators

Market Signals
Indicator
CLBT
RCUS
Relative Strength Index (RSI) 37.32 36.77
Support Level $10.81 $17.47
Resistance Level $11.75 $19.63
Average True Range (ATR) 0.57 0.97
MACD -0.04 0.21
Stochastic Oscillator 3.71 17.84

Price Performance

Historical Comparison
CLBT
RCUS

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: